Russia’s antitrust regulator, the Federal Antimonopoly service (FAS), opened an investigation into possible cartel behavior from 5 companies offering medical supplies and equipment through public sector auctions across the Russian Federation.
The companies being investigated include Metrolife, Promezhutki, Medtorg, Infamed and Micromed. The companies are suspected of maintaining prices at auctions of cardiology products. According to the FAS, the companies colluded on at least 357 auctions from 2015 to 2017.
The FAS stated that the “potential cartel is one of the largest scale. The amount of initial maximum prices of contracts amounted to more than 2.5 billion rubles (US$42.1 million).”
Full Content: FreeNews English
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
DOJ and FTC Introduce Website for Reporting Anti-Competitive Healthcare Practices
Apr 18, 2024 by
CPI
US Congress Advances Legislation to Compel TikTok Sale
Apr 18, 2024 by
CPI
UK Financial Sector Advocates Enhanced Regulatory Accountability
Apr 18, 2024 by
CPI
Google and All 50 States Defend $700 Million Consumer Settlement
Apr 18, 2024 by
CPI
Colorado Enacts First Law to Protect Consumer Brainwave Data
Apr 18, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – China Edition – Year of the Dragon
Apr 16, 2024 by
CPI
Review Logic and Rules for Concentrations of Undertakings that Do Not Meet the Standard of Notification
Apr 16, 2024 by
CPI
China’s Review of Semiconductor Transactions
Apr 16, 2024 by
CPI
Key Challenges and Tips for Merger Control Filing in China for Listed Companies
Apr 16, 2024 by
CPI
Key Point Review: China SPC Antitrust Judgments in 2023
Apr 16, 2024 by
CPI